A recent study from Sweden is shedding light on the potential association between the use of antiviral medications during pregnancy and the risk of developing preeclampsia. preeclampsia, a serious pregnancy complication characterized by high blood pressure and organ damage, affects 2-8% of pregnancies worldwide and can lead to significant health risks for both mother and child. The research,leveraging comprehensive data from Swedish national registers,aims to provide clarity on this important issue.
Researchers in sweden conducted a register-based study using data from several national sources, including the Swedish Medical Birth Register (MBR), the Swedish National Patient Register (NPR), the Swedish National Prescribed Drug Register (NPDR), and Statistics Sweden. The MBR, which has been collecting data on all births in Sweden as 1973, records information from the mother’s first antenatal visit through hospital discharge. The NPR provides data on the mother’s medical history, while the NPDR tracks all medications dispensed by Swedish pharmacies.
The study focused on women giving birth to their first child in Sweden between 2007 and 2019. Pregnancies ending in stillbirth after the 22nd gestational week were included, but twin pregnancies were excluded from the analysis. Gestational length at delivery was primarily calculated based on routine antenatal ultrasounds.
Did You Know? The Swedish Medical Birth Register has been collecting comprehensive data on births for over 50 years, providing a rich resource for epidemiological research.
Defining and Categorizing preeclampsia
Preeclampsia was identified using ICD-10 codes (O11, O14, O15 and O16) recorded in the NPR. The researchers distinguished between different preeclampsia outcomes based on gestational age at delivery and infant growth:
- Preeclampsia with early preterm delivery (before week 34)
- Preterm preeclampsia (before week 37)
- term preeclampsia (after week 37)
- preeclampsia with a small-for-gestational-age infant (SGA), defined as birthweight below two standard deviations of mean birthweight for gestational age and fetal sex.
Statistical Analysis Methods
The study presented population characteristics according to antiviral medication use, further categorizing women by the timing of their first dispensed prescription. Results were presented as unadjusted and adjusted odds ratios, with 95% confidence intervals. as a sensitivity analysis, the group unexposed to antiviral medications was divided according to HSV status, and logistic regression was used to explore differences in preeclampsia likelihood among the three groups.
All statistical analyses were performed using R Statistical Software.A p-value below 0.05 was considered statistically significant.
Pro Tip: Directed acyclic graphs (DAGs) are valuable tools for identifying potential confounders in observational studies, helping researchers to minimize bias in their analyses.
Addressing Confounders and Bias
Possible confounders were evaluated using a directed acyclic graph (DAG), considering clinical risk factors for preeclampsia from existing literature. The identified confounders included maternal age, BMI, country of birth, IVF use, smoking at the first antenatal visit, pre-gestational diabetes, chronic hypertension, chronic kidney disease, and systemic lupus erythematosus.
To further address potential bias, the researchers used inverse probability of treatment weighting (IPTW) to adjust for baseline characteristics between women who used antiviral medications and those who did not. Propensity scores were calculated using the exposure as the outcome, and covariate balance was assessed graphically. Missing BMI values were imputed using the mice R package with predictive mean matching (pmm), and the analysis was repeated for each imputed dataset.
| Outcome | Definition |
|---|---|
| Preeclampsia with early preterm delivery | Preeclampsia with delivery before week 34 |
| Preterm preeclampsia | Preeclampsia with delivery before week 37 |
| Term preeclampsia | Preeclampsia with delivery after week 37 |
| Preeclampsia with SGA | Preeclampsia with a small-for-gestational-age infant |
Model fit and adjusted odds ratios were calculated for each BMI imputation, with results pooled using Rubin’s combining rule.For time of exposure subgroup analysis, a new propensity score was calculated for each of the three timepoints.
eight individuals were excluded from analyses involving different preeclampsia outcomes due to unknown gestational age.
Future Research and Implications
This study provides valuable insights into the potential relationship between antiviral medication use and preeclampsia risk during pregnancy. Further research is needed to confirm these findings and to explore the underlying mechanisms. Understanding these associations can definitely help inform clinical guidelines and improve pregnancy outcomes.
What are your thoughts on the use of antiviral medications during pregnancy? How can we better inform pregnant women about the potential risks and benefits?
Evergreen Insights: Understanding Preeclampsia
Preeclampsia is a pregnancy-specific condition characterized by the onset of hypertension and proteinuria (or other organ dysfunction) after 20 weeks of gestation.It is a leading cause of maternal and perinatal morbidity and mortality worldwide. Risk factors for preeclampsia include nulliparity (first pregnancy), multiple gestation, pre-existing hypertension, diabetes, kidney disease, and autoimmune disorders. Early detection and management are crucial to prevent severe complications such as eclampsia (seizures), stroke, and organ failure.
According to the Centers for Disease Control and Prevention (CDC), preeclampsia affects about 1 in 25 pregnancies in the United States. while the exact cause of preeclampsia is unknown, it is indeed thought to involve abnormal progress of the placenta. Treatment typically involves close monitoring of blood pressure and organ function, and delivery of the baby is often necessary to resolve the condition.
Frequently Asked Questions About Preeclampsia
- What are the symptoms of preeclampsia?
- Symptoms of preeclampsia can include high blood pressure,protein in the urine,severe headaches,vision changes,abdominal pain,and swelling in the hands and face. Some women with preeclampsia may not experience any noticeable symptoms.
- How is preeclampsia diagnosed?
- Preeclampsia is typically diagnosed based on blood pressure measurements and urine tests. Additional tests might potentially be performed to assess organ function and fetal well-being.
- What are the risk factors for preeclampsia?
- Risk factors for preeclampsia include first pregnancy, multiple gestation, pre-existing hypertension, diabetes, kidney disease, autoimmune disorders, obesity, and a family history of preeclampsia.
- How is preeclampsia treated?
- The primary treatment for preeclampsia is delivery of the baby. In certain specific cases, medication might potentially be used to control blood pressure and prevent seizures until delivery is absolutely possible.
- Can preeclampsia be prevented?
- There is no guaranteed way to prevent preeclampsia, but certain measures may reduce the risk, such as maintaining a healthy weight, controlling blood pressure and blood sugar, and taking low-dose aspirin as recommended by a healthcare provider.
Disclaimer: This article provides general information and should not be considered medical advice. Consult with a healthcare professional for personalized guidance and treatment.
Share this article to raise awareness about preeclampsia and its potential risk factors. What other questions do you have about pregnancy health?